In the study reported by Leuci et al., the tumor elimination in vitro after treatment with CSPG4-CAR.CIKs was dependent on the expression level of tumor cells, suggesting that "CSPG4-high" STS should represent the most candidate population for such treatment [30]. This evidence concerns the gene TRAF3IP2 and neoplasm.